CN112342247B - 一种提高家蚕细胞表达外源蛋白分泌率的方法 - Google Patents
一种提高家蚕细胞表达外源蛋白分泌率的方法 Download PDFInfo
- Publication number
- CN112342247B CN112342247B CN202011247477.1A CN202011247477A CN112342247B CN 112342247 B CN112342247 B CN 112342247B CN 202011247477 A CN202011247477 A CN 202011247477A CN 112342247 B CN112342247 B CN 112342247B
- Authority
- CN
- China
- Prior art keywords
- cells
- expression
- bip
- secretion rate
- foreign protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 59
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 50
- 230000028327 secretion Effects 0.000 title claims abstract description 46
- 241000255789 Bombyx mori Species 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title abstract description 14
- 230000014509 gene expression Effects 0.000 claims abstract description 54
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 25
- 108091030071 RNAI Proteins 0.000 claims abstract description 20
- 230000009368 gene silencing by RNA Effects 0.000 claims abstract description 20
- 239000013604 expression vector Substances 0.000 claims abstract description 8
- 239000012634 fragment Substances 0.000 claims abstract description 5
- 230000002452 interceptive effect Effects 0.000 claims abstract description 5
- 101001001300 Human cytomegalovirus (strain Towne) 65 kDa phosphoprotein Proteins 0.000 claims description 8
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 101150084084 BiP gene Proteins 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract description 15
- 102000018697 Membrane Proteins Human genes 0.000 abstract description 9
- 241000701447 unidentified baculovirus Species 0.000 abstract description 4
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 230000007246 mechanism Effects 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 72
- 108091008324 binding proteins Proteins 0.000 description 26
- 102000023732 binding proteins Human genes 0.000 description 23
- 239000013612 plasmid Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 11
- 108060001084 Luciferase Proteins 0.000 description 8
- 239000005089 Luciferase Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108020004459 Small interfering RNA Proteins 0.000 description 7
- 238000001890 transfection Methods 0.000 description 7
- 238000011529 RT qPCR Methods 0.000 description 5
- 108010084455 Zeocin Proteins 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000040739 Secretory proteins Human genes 0.000 description 4
- 108091058545 Secretory proteins Proteins 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000010473 stable expression Effects 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001027081 Homo sapiens Killer cell immunoglobulin-like receptor 2DL1 Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100037363 Killer cell immunoglobulin-like receptor 2DL1 Human genes 0.000 description 1
- 108010036176 Melitten Proteins 0.000 description 1
- -1 antibodies Proteins 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical group NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/103—Plasmid DNA for invertebrates
- C12N2800/105—Plasmid DNA for invertebrates for insects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011247477.1A CN112342247B (zh) | 2020-11-10 | 2020-11-10 | 一种提高家蚕细胞表达外源蛋白分泌率的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011247477.1A CN112342247B (zh) | 2020-11-10 | 2020-11-10 | 一种提高家蚕细胞表达外源蛋白分泌率的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112342247A CN112342247A (zh) | 2021-02-09 |
CN112342247B true CN112342247B (zh) | 2022-03-11 |
Family
ID=74363281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011247477.1A Active CN112342247B (zh) | 2020-11-10 | 2020-11-10 | 一种提高家蚕细胞表达外源蛋白分泌率的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112342247B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2643468T3 (pl) * | 2010-11-22 | 2018-11-30 | Amicus Therapeutics, Inc. | Nowe sekwencje sygnałowe do poprawy ekspresji białek i wydzielania ekombinowanych enzymów i innych białek |
CN103205398A (zh) * | 2013-04-11 | 2013-07-17 | 山西大学 | 高效表达grp78蛋白的dld1稳定细胞株及其构建方法 |
KR102259028B1 (ko) * | 2014-07-30 | 2021-06-02 | 다이이찌 산쿄 가부시키가이샤 | 단백질의 개량 고분비 생산 방법 |
CN104450706B (zh) * | 2014-12-10 | 2017-04-05 | 中山大学 | 利用rna干扰技术诱导凡纳滨对虾血淋巴细胞发生upr的方法 |
EP3682012A1 (en) * | 2017-09-11 | 2020-07-22 | R. J. Reynolds Tobacco Company | Methods and compositions for increasing expression of genes of interest in a plant by co-expression with p21 |
-
2020
- 2020-11-10 CN CN202011247477.1A patent/CN112342247B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112342247A (zh) | 2021-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5735927B2 (ja) | タンパク質生産の増強のためのmRNAの一次構造の再操作 | |
CN106148286B (zh) | 一种用于检测热原的细胞模型的构建方法和细胞模型及热原检测试剂盒 | |
KR100990055B1 (ko) | 유전자 발현 억제 방법 | |
CN107828738A (zh) | 一种dna甲基转移酶缺陷型cho细胞系及其制备方法及应用 | |
EP2937417B1 (en) | MiRNAs enhancing cell productivity | |
CN107513531A (zh) | 用于内源性过表达lncRNA‑XIST的gRNA靶点序列及其应用 | |
Park et al. | Agrobacterium tumefaciens-mediated transformation of the lichen fungus, Umbilicaria muehlenbergii | |
WO2016029802A1 (zh) | 虫草素的合成基因簇的鉴定和应用 | |
CN110055283A (zh) | 目的基因多拷贝整合的方法、重组菌、白藜芦醇以及重组人血清白蛋白的制备方法 | |
CN112342247B (zh) | 一种提高家蚕细胞表达外源蛋白分泌率的方法 | |
JP7382138B2 (ja) | Hspa5遺伝子のプロモーター | |
CN114836418A (zh) | 用于敲降猪流行性腹泻病毒的CRISPR-Cas13d系统 | |
CN108486153B (zh) | FGF2与TGF-β1融合基因在促进蚕丝细胞增殖活性和抗炎功能中的应用及方法 | |
Bao et al. | Direct interactions between bidensovirus B m DNV‐Z proteins and midgut proteins from the virus target B ombyx mori | |
CN114107330B (zh) | 一种家蚕γ-干扰素诱导的硫醇还原酶类似物基因的CDS序列及其应用 | |
US20220348941A1 (en) | Genetically modified recombinant cell lines | |
CN112336732B (zh) | 一种组合物及其抗菌应用 | |
KR20210095294A (ko) | 돼지생식기호흡기증후군 바이러스의 감염력 향상 또는 억제를 위한 돼지 대식세포 분화 및 극성화 방법 | |
CN110607312A (zh) | 一种黄曲霉致病基因hsp90及其应用 | |
CN114317535B (zh) | 基因缺失cho细胞系及其制备方法及应用 | |
CN114410680B (zh) | Dph6基因在制备具有毒素抗性细胞系中的应用 | |
CN115948469A (zh) | 一种提高家蚕细胞表达外源蛋白分泌率的方法 | |
KR102272651B1 (ko) | 외래단백질의 발현량과 발현시간이 증대된 배큘로바이러스 | |
CN107365770B (zh) | 针对自噬相关基因Beclin1编码区174-194位点的siRNA序列及其应用 | |
CN116531488A (zh) | 转运蛋白tspo及其激动剂、抑制剂在家蚕微孢子虫相关药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230104 Address after: 230000 B-2705, wo Yuan Garden, 81 Ganquan Road, Shushan District, Hefei, Anhui. Patentee after: HEFEI LONGZHIYUN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: Science and Technology Office of Jiangsu University of science and technology, No.2, Mengxi Road, Zhenjiang, Jiangsu, 212003 Patentee before: JIANGSU University OF SCIENCE AND TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230425 Address after: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee after: Shanghai Wuxin Dacheng Medical Technology (Group) Co.,Ltd. Address before: 230000 B-2705, wo Yuan Garden, 81 Ganquan Road, Shushan District, Hefei, Anhui. Patentee before: HEFEI LONGZHIYUN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee after: Shanghai Wuxin Medical Technology Group Co.,Ltd. Country or region after: China Address before: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee before: Shanghai Wuxin Dacheng Medical Technology (Group) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |